Cite Filings / ALGS / 0001193125-26-281134

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Aligos Therapeutics, Inc. Filed 2026-06-24 Acc 0001193125-26-281134

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-06-29 4 Options or other derivatives
2026-06-29 4 Options or other derivatives
2026-06-29 4 Options or other derivatives
2026-06-29 4 Options or other derivatives
2026-06-29 4 Options or other derivatives
2026-06-26 8-K Executive or director change · Shareholder vote results
2026-06-24 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…